Trials / Completed
CompletedNCT06870539
Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 49 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the feasibility and accuracy of using saliva to remotely monitor cytomegalovirus (CMV) infection in individuals receiving treatment for ovarian cancer.
Conditions
- Cancer-related Cognitive Dysfunction
- Cytomegaloviral Infection
- Fallopian Tube Carcinoma
- Ovarian Carcinoma
- Primary Peritoneal Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-Interventional Study |
Timeline
- Start date
- 2025-03-07
- Primary completion
- 2025-07-31
- Completion
- 2025-07-31
- First posted
- 2025-03-11
- Last updated
- 2025-12-04
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06870539. Inclusion in this directory is not an endorsement.